Enanta Pharmaceuticals Inc. logo

Enanta Pharmaceuticals Inc. (ENTA)

Market Open
12 Jun, 17:54
NASDAQ (NGS) NASDAQ (NGS)
$
11. 90
+0.39
+3.4318%
$
272.33M Market Cap
- P/E Ratio
- Div Yield
25,080 Volume
-5.15 Eps
$ 11.51
Previous Close
Add Transaction
Day Range
11.11 12.1
Year Range
6.43 17.15
Want to track ENTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Enanta Pharmaceuticals Inc. (ENTA) Statistics

Valuation metrics

Market Cap 272.33M
Enterprise value 413.57M
Trailing P/E (ttm) -5.26
Forward P/E -
PEG ratio -0.1
Price/Sales (ttm) 3.78
Price/Book (mrq) 2.8
Enterprise Value/Revenue 5.98
Enterprise Value/EBITDA -8.5

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 211.87K
Average volume (90 days) 167.14K

Price summary

52-Week low 6.43
52-Week high 17.15
Beta -
50-Day moving average 13.66
200-Day moving average 13.75

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.9%
Operating margin -0.87%

Operational effectiveness

Return on assets -0.2%
Return on equity -0.64%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 2.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.15
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 5.67
Total debt (mrq) -
Total Debt/Equity (mrq) 1.6
Current ratio (mrq) 3.84%
Book value per share (mrq) 4.04

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -